Last reviewed · How we verify

Pretreatment With Norethindrone Acetate Prior to Levonorgestrel IUS Insertion for Heavy Menstrual Bleeding (Mirena IUD)

NCT01391052 Phase 4 UNKNOWN

Problematic uterine bleeding after the insertion of the LNG IUS is a well documented side effect. The levonorgestrel intrauterine system (LNG IUS) was approved for treatment of heavy menstrual bleeding (HMB) by the FDA in October 2009. To reduce the incidence and severity of post-insertional uterine bleeding, pretreatment with norethindrone acetate may effectively slough the endometrium prior to insertion of the LNG IUS.

Details

Lead sponsorScott and White Hospital & Clinic
PhasePhase 4
StatusUNKNOWN
Enrolment80
Start date2011-01
Completion2013-01

Conditions

Interventions

Primary outcomes

Countries

United States